Ming-Qiang Zheng - JoVE Visualize

Showing results (51-60 of 63) with videos related to

Pageof 7

Sort By:

Neuroimage|May 22, 2014

Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242Mika Naganawa, Leslie K Jacobsen, Ming-Qiang Zheng, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2013

Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imagingMing-Qiang Zheng, Nabeel Nabulsi, Su Jin Kim, et al.

Alcoholism, Clinical and Experimental Research|May 4, 2012

Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependenceAlexander Neumeister, Marc D Normandin, James W Murrough, et al.

Molecules (Basel, Switzerland)|October 17, 2015

A Promising PET Tracer for Imaging of α₇ Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based RadioligandRodrigo Teodoro, Matthias Scheunemann, Winnie Deuther-Conrad, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013

Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastomaJiangbing Zhou, Toral R Patel, Rachael W Sirianni, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 12, 2014

Phosphodiesterase 10A PET radioligand development program: from pig to humanChristophe Plisson, David Weinzimmer, Steen Jakobsen, et al.

Neuroimage|October 15, 2022

Age, gender and body-mass-index relationships with in vivo CB1 receptor availability in healthy humans measured with [11C]OMAR PETRajiv Radhakrishnan, Patrick D Worhunsky, Ming-Qiang Zheng, et al.

European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2023

Preclinical evaluation of a brain penetrant PARP PET imaging probe in rat glioblastoma and nonhuman primatesBaosheng Chen, Devi Prasan Ojha, Takuya Toyonaga, et al.

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 25, 2022

Comparison of three novel radiotracers for GluN2B-containing NMDA receptors in non-human primates: (R)-[11C]NR2B-Me, (R)-[18F]of-Me-NB1, and (S)-[18F]of-NB1Kelly Smart, Ming-Qiang Zheng, Hazem Ahmed, et al.

European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2017

PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humansAnsel T Hillmer, Songye Li, Ming-Qiang Zheng, et al.

Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:

Pageof 7

Neuroimage|May 22, 2014

Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242Mika Naganawa, Leslie K Jacobsen, Ming-Qiang Zheng, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2013

Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imagingMing-Qiang Zheng, Nabeel Nabulsi, Su Jin Kim, et al.

Alcoholism, Clinical and Experimental Research|May 4, 2012

Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependenceAlexander Neumeister, Marc D Normandin, James W Murrough, et al.

Molecules (Basel, Switzerland)|October 17, 2015

A Promising PET Tracer for Imaging of α₇ Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based RadioligandRodrigo Teodoro, Matthias Scheunemann, Winnie Deuther-Conrad, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013

Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastomaJiangbing Zhou, Toral R Patel, Rachael W Sirianni, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 12, 2014

Phosphodiesterase 10A PET radioligand development program: from pig to humanChristophe Plisson, David Weinzimmer, Steen Jakobsen, et al.

Neuroimage|October 15, 2022

Age, gender and body-mass-index relationships with in vivo CB1 receptor availability in healthy humans measured with [11C]OMAR PETRajiv Radhakrishnan, Patrick D Worhunsky, Ming-Qiang Zheng, et al.

European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2023

Preclinical evaluation of a brain penetrant PARP PET imaging probe in rat glioblastoma and nonhuman primatesBaosheng Chen, Devi Prasan Ojha, Takuya Toyonaga, et al.

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 25, 2022

Comparison of three novel radiotracers for GluN2B-containing NMDA receptors in non-human primates: (R)-[11C]NR2B-Me, (R)-[18F]of-Me-NB1, and (S)-[18F]of-NB1Kelly Smart, Ming-Qiang Zheng, Hazem Ahmed, et al.

European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2017

PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humansAnsel T Hillmer, Songye Li, Ming-Qiang Zheng, et al.

Pageof 7